Hongxing Ma

1.4k citations
15 papers · 1.0k indexed · 1 hit paper · h-index 9
Topics
Cytokine Signaling Pathways and Interactions (3 papers)Botulinum Toxin and Related Neurological Disorders (2 papers)Neurological disorders and treatments (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Hongxing Ma

14 papers receiving 1.0k citations

Hit Papers

The role of JAK/STAT signaling pathway and its inhibitors...20202026202220242020200400600

Peers

Hongxing Ma
Comparison fields: 5 of 97
  • Molecular Biology 397
  • Immunology 231
  • Oncology 213
  • Rheumatology 191
  • Cancer Research 136
Replace Maorong Fu with:
Maorong Fu China
Xiaoyi Jia China
Xiaojian Huang China
Haihong Qin China
Xuezhi Yang China
Junzheng Yang China
Rhiannon Morris Australia
Fan Xiao China
Xiong Li China
Hongxing Ma relative to Maorong Fu China Maorong Fu's profile →
Citations per field
00.5×1.5×
Maorong Fu · 1×
Citations per year

Countries citing papers authored by Hongxing Ma

Since Specialization
Citations

This map shows the geographic impact of Hongxing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxing Ma more than expected).

Fields of papers citing papers by Hongxing Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxing Ma. The network helps show where Hongxing Ma may publish in the future.

Co-authorship network of co-authors of Hongxing Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxing Ma. A scholar is included among the top collaborators of Hongxing Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxing Ma. Hongxing Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 8
3 3
4 156
5
The role of JAK/STAT signaling pathway and its inhibitors in diseasesbreakdown →
688
6 6
7 8
8 8
9 25
10 1
11 26
12 4
13 24
14 49
15 4

About Hongxing Ma

Hongxing Ma is a scholar working on Pharmacology, Rheumatology and Geology, having authored 15 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Neurological disorders and treatments (2 papers). The work is most often cited by research in Rheumatology (191 citations), Pharmacology (99 citations) and Immunology (231 citations). Hongxing Ma has collaborated with scholars based in China and United States. Frequent co-authors include Ping Xin, Shiqin Sun, Xuegang Zhou, Youzhi Wang, Shuang Liu, Xiaoyun Xu, Shuang Liu, Huaxi Zhang, Jing Pang and Frederick S. Kaplan. Their work appears in journals such as Journal of Ethnopharmacology, Bone and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026